GALDERMA: THE OFFERING CONSISTS OF UP TO 40,453,467 NEWLY ISSUED REGISTERED SHARES AND UP TO 276,909 EXISTING REGISTERED SHARE
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.09 CHF | +0.75% | +3.78% | 0.00% |
May. 03 | Dr. Reddy's Laboratories Launches Generic Doxycycline Capsules in US | MT |
Apr. 30 | CVC weighs options for DKV Mobility stake as IPO plans shelved, sources say | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 18.62B | |
+0.71% | 257B | |
+5.60% | 11.04B | |
-10.59% | 9.45B | |
+16.48% | 7.4B | |
+16.30% | 6.2B | |
+1.78% | 4.78B | |
-15.73% | 3.79B | |
-5.06% | 3.54B | |
-9.36% | 3.52B |
- Stock Market
- Equities
- GALD Stock
- News Galderma Group AG
- Galderma: The Offering Consists Of Up To 40,453,467 Newly Issu…